Europe Drug Delivery Market By Route of Administration Analysis (Pulmonary drug delivery, Ocular drug delivery, Topical drug delivery, Transmucosal drug delivery, Oral drug delivery, Injectable drug delivery, Nasal drug delivery, Implantable drug delivery); By End-user Analysis (Diagnostic centers, Home care settings, ASCs/ Clinics, Hospitals) and By Regional Analysis – Forecast by 2023 - 2028
The Europe Drug Delivery Market is expected to exceed more than US$ 700 Million by 2028 at a CAGR of 7% in the given forecast period.
COVID-19 Impact Analysis Report
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
7
REPORT DESCRIPTION
Drug delivery systems are designed advancements for the targeted shipping and managed launch of healing dealers. Drug delivery is the technique or strategy of managing a pharmaceutical compound to fulfill a therapeutic effect in individuals or creatures. For the treatment of human infections, nasal and aspiratory courses of pharmaceutical transport are expanding growing criticalness. These courses give promising different alternatives to parenteral prescription movement particularly for peptide and protein therapeutics. Thus, a couple of prescription transport structures have been point by point and are being inspected for nasal and aspiratory movement. These join cyclodextrins, prodrugs, gels, microspheres, proliposomes and liposomes.
How Big is the Europe Drug Delivery Market?
The Europe Drug Delivery Market is expected to exceed more than US$ 700 Million by 2028 at a CAGR of 7% in the given forecast period.
The major driving factors of Europe Drug Delivery Market are as follows:
The restraining factors of Europe Drug Delivery Market are as follows:
The Europe Drug Delivery Market is segmented on the lines of its route of administration, end user and regional. Based on route of administration segmentation it covers pulmonary drug delivery, ocular drug delivery, topical drug delivery, transmucosal drug delivery, oral drug delivery, injectable drug delivery, nasal drug delivery and implantable drug delivery. Pulmonary drug delivery is further segmented into nebulizers, dry powder inhaler and metered dose inhaler. Ocular drug delivery segmentation contains ocular devices, semi solid and liquid. Under tropical drug delivery it covers transdermal, solid, semi solid and liquid. Transmucosal drug delivery segmentation covers oral and other. Based on oral drug delivery segmentation it covers liquid, solid and semi solid. Under injectable drug delivery segmentation it contains devices and formulations. The drug delivery technology market is segmented on the lines of its nasal drug delivery like nasal gels, nasal powder, nasal spray and nasal drops. Under implantable drug delivery segmentation it covers passive implantable drug delivery and active implantable drug delivery. Based on end user segmentation it covers diagnostic centers, home care settings, ASCs/ clinics, hospitals and other end users. The Europe Drug Delivery Market on geographic segmentation covers various regions such as Germany, France, United Kingdom, Spain, Italy, Russia and Rest of Europe (ROE)
This report provides:
1) An overview of the global market for Europe Drug Delivery and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for Europe Drug Delivery Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets on Europe Drug Delivery Market with the reasons given for variations in the growth of the industry in certain regions.
The report mentions the detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include 3M Company, Alkermes, Inc., Becton, Dickinson And Company, Cima Labs, Dali Medical Devices, Foamix, Johnson & Johnson, Inc., Psivida Corporation, SkyepharmaPlc, Valeant Pharmaceuticals, Ypsomed Holding AG. Company profile includes details such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Europe Drug Delivery Market has been segmented as below:
By Route of Administration Analysis:
By End-user Analysis
By Regional Analysis
Reasons to Buy this Report:
1) Get the most up to date information available on all Europe Drug Delivery in the market globally.
2) Identify growth segments and opportunities in the industry.
3) Report includes decision making on the basis of strong historic and forecast of Europe Drug Delivery Market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
Below are our new reports:
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Executive Summary
3 Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.1.1 Patent Cliff And Increased Competition To Increase Adoption Rate
3.2.1.2 Improving Patient Compliance And Acceptability, An Impetus To The Drug Delivery Systems Market
3.2.1.3 Increasing Focus On Pediatric And Geriatric Patients To Boost Overall Growth
3.2.1.4 Increasing Incidence Of Chronic Diseases Like Cancer And Diabetes To Enhance Demand For Drug Delivery Technologies
3.2.1.5 Higher Premature Mortality Rates In Eastern Europe And Russia Suggests Need For Better Medication
3.2.2 Restraints
3.2.2.1 Drug Failures And Recalls Mar Market Growth
3.2.2.2 Technical Barriers Restrict Growth
3.2.3 Opportunities
3.2.3.1 Collaborations Between Pharmaceutical Companies And Drug Delivery Firms
3.2.3.2 Self-Administration And Home Care Drug Delivery Devices
3.2.3.3 Expanding Therapeutic Applications Of Drug Delivery Technologies
3.2.4 Targeted Drug Delivery
3.2.4.1 Passive Systems Contribute 60% To The Targeted Drug Delivery Market
3.2.4.2 Active Targeted Drug Delivery Has Major Applications In Cancer Therapy
3.2.4.3 Companies Focus On Novel Targeted Drug Delivery
3.2.5 Burning Issues
3.2.5.1 Striking Right Partnerships
3.2.5.2 Improving The Bioavailability Of Drugs
3.3 Regulatory Affairs
3.3.1 European Union Regulatory Framework
3.3.2 Germany
3.3.2.1 Bundesministerium Für Gesundheit (Ministry Of Health)
3.3.2.2 Bundesinstitut Für Arzneimittel Und Medizinprodukte (Federal Institute For Drugs And Medical Devices)
3.3.3 U.K.
3.3.3.1 The Medicines And Healthcare Products Regulatory Agency (MHRA)
3.3.4 France
3.3.4.1 Agence Nationale De Sécurité Du Médicament Et Des Produits De Santé (National Agency For The Safety Of Medicines And Health Products)
3.3.5 Spain
3.3.5.1 Agencia Espagnola De Medicamentos Y Productos Sanitarios (Spanish Medicines And Health Products Agency)
3.3.6 Italy
3.3.6.1 Agenzia Italiana Del Farmaco (Italian Medicines Agency)
3.3.7 Russia
3.3.7.1 Association Of International Pharmaceutical Manufacturers (AIPM)
3.4 Reimbursement Scenario In The European Union
3.5 Market Segmentation
3.6 Porter’s Five Forces Analysis
3.7 Value Chain Analysis
3.8 Market Share Analysis
3.8.1 Pulmonary Drug Delivery
3.8.2 Injectable Drug Delivery
3.8.2.1 Conventional Injection Devices
3.8.2.2 Self-Injection Devices
4 Global Drug Delivery Market, By Technology
4.1 Introduction
4.2 Opportunity Matrix
4.3 Oral Drug Delivery
4.3.1 Controlled Release
4.3.2 Orodispersible Tablets (ODT) And Taste Masking
4.3.3 Others
4.4 Pulmonary Drug Delivery
4.4.1 Therapeutic Applications Of Pulmonary Delivery
4.4.2 Metered Dose Inhalers (MDI)
4.4.3 Dry Powder Inhalers (DPI)
4.4.4 Nebulizers
4.5 Transdermal Drug Delivery
4.5.1 Passive Transdermal Drug Delivery
4.5.1.1 Matrix System
4.5.1.2 Reservoir System
4.5.2 Active Transdermal Drug Delivery
4.5.2.1 Microporation
4.5.2.2 Iontophoresis
4.5.2.3 Others
4.6 Injectable Drug Delivery
4.6.1 Conventional Injectable Drug Delivery Devices
4.6.1.1 Fillable
4.6.1.2 Prefilled
4.6.2 Self-Injection Devices
4.6.2.1 Pen Injectors
4.6.2.2 Needle-Free Injectors
4.6.2.3 Auto Injectors
4.6.3 Others
4.7 Ocular Drug Delivery
4.7.1 Eye Drops
4.7.2 Ointments And Gels
4.7.3 Others
4.8 Nasal Drug Delivery
4.8.1 Nasal Sprays
4.8.2 Nasal Inhalers
4.8.3 Nasal Drops
4.8.4 Others
4.9 Topical Drug Delivery
4.9.1 Semi-Solid Formulations
4.9.2 Liquid Formulations
4.9.3 Solid Formulations
4.10 Implantable Drug Delivery
4.10.1 Drug- Eluting Stents
4.10.2 Implantable Infusion Pumps
4.10.3 Contraceptive Implants
4.10.4 Intraocular Implants
4.10.5 Brachytherapy Seeds
4.11 Transmucosal Drug Delivery
4.11.1 Oral (Buccal And Sublingual)
4.11.2 Others (Rectal, Vaginal)
5 Geographic Analysis
5.1 Introduction
5.2 Germany
5.3 France
5.4 U.K.
5.5 Spain
5.6 Italy
5.7 Russia
5.8 Rest Of Europe (ROE)
6 Competitive Landscape
6.1 Introduction
6.2 New Product Launch
6.3 Agreements, Collaborations, Joint Ventures & Partnerships
6.4 Mergers & Acquisitions
6.5 Other Developments
7 Company Profiles
7.1 3M Company
7.2 Alkermes, Inc.
7.3 Becton, Dickinson And Company
7.4 Cima Labs
7.5 Dali Medical Devices
7.6 Foamix
7.7 Johnson & Johnson, Inc.
7.8 Psivida Corporation
7.9 Skyepharma Plc
7.10 Valeant Pharmaceuticals
7.11 Ypsomed Holding AG
The Europe Drug Delivery Market has been segmented as below:
By Route of Administration Analysis:
By End-user Analysis
By Regional Analysis
Got a question? We've got answers. If you have some other questions, see our support center.
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE